Meiji Yasuda Asset Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$996K Sell
2,555
-5,070
-66% -$2.14M 0.04% 277
2026
Q1
$3.61M Sell
7,625
-602
-7% -$303K 0.18% 150
2025
Q4
$3.84M Sell
8,227
-1,413
-15% -$656K 0.18% 154
2025
Q3
$4.11M Sell
9,640
-57
-0.6% -$22.1K 0.2% 146
2025
Q2
$3.71M Buy
9,697
+5,254
+118% +$1.89M 0.18% 156
2025
Q1
$1.54M Sell
4,443
-643
-13% -$207K 0.06% 264
2024
Q4
$1.53M Sell
5,086
-6,351
-56% -$2.22M 0.06% 258
2024
Q3
$4.65M Sell
11,437
-840
-7% -$308K 0.18% 145
2024
Q2
$3.94M Buy
12,277
+7
+0.1% +$2.27K 0.16% 149
2024
Q1
$4.09M Buy
12,270
+54
+0.4% +$16.5K 0.17% 148
2023
Q4
$3.31M Buy
12,216
+7,110
+139% +$1.76M 0.15% 178
2023
Q3
$1.26M Buy
5,106
+350
+7% +$95.8K 0.06% 291
2023
Q2
$1.44M Buy
4,756
+150
+3% +$41.7K 0.07% 248
2023
Q1
$1.22M Sell
4,606
-270
-6% -$68.6K 0.06% 264
2022
Q4
$1.17K Sell
4,876
-230
-5% -$51.5K 0.06% 294
2022
Q3
$938K Sell
5,106
-256
-5% -$51K 0.05% 313
2022
Q2
$901K Sell
5,362
-645
-11% -$139K 0.05% 343
2022
Q1
$1.5M Sell
6,007
-1,268
-17% -$318K 0.08% 256
2021
Q4
$1.87M Buy
7,275
+132
+2% +$32.3K 0.12% 179
2021
Q3
$1.73M Sell
7,143
-238
-3% -$58.2K 0.12% 172
2021
Q2
$1.53M Sell
7,381
-234
-3% -$47.7K 0.07% 199
2021
Q1
$1.43M Buy
7,615
+1,125
+17% +$198K 0.11% 189
2020
Q4
$1.07M Sell
6,490
-230
-3% -$33.6K 0.11% 197
2020
Q3
$838K Sell
6,720
-1,970
-23% -$244K 0.09% 197
2020
Q2
$843K Buy
8,690
+1,970
+29% +$205K 0.08% 229
2020
Q1
$604K Sell
6,720
-2,220
-25% -$287K 0.11% 154
2019
Q4
$1.32M Sell
8,940
-1,440
-14% -$193K 0.11% 201
2019
Q3
$1.25M Sell
10,380
-2,030
-16% -$262K 0.1% 219
2019
Q2
$1.68M Sell
12,410
-1,715
-12% -$217K 0.14% 164
2019
Q1
$1.84M Sell
14,125
-780
-5% -$105K 0.16% 157
2018
Q4
$1.85M Sell
14,905
-1,590
-10% -$213K 0.17% 157
2018
Q3
$2.29M Buy
16,495
+4,210
+34% +$524K 0.19% 138
2018
Q2
$1.26M Buy
12,285
+8,425
+218% +$852K 0.11% 206
2018
Q1
$374K Hold
3,860
0.04% 409
2017
Q4
$339K Hold
3,860
0.03% 423
2017
Q3
$307K Sell
3,860
-1,400
-27% -$113K 0.03% 427
2017
Q2
$459K Sell
5,260
-2,700
-34% -$228K 0.05% 368
2017
Q1
$708K Buy
7,960
+3,170
+66% +$264K 0.08% 277
2016
Q4
$355K Sell
4,790
-160
-3% -$12K 0.04% 397
2016
Q3
$374K Sell
4,950
-6,435
-57% -$493K 0.04% 370
2016
Q2
$877K Buy
11,385
+2,450
+27% +$193K 0.13% 191
2016
Q1
$697K Sell
8,935
-120
-1% -$8.38K 0.16% 139
2015
Q4
$612K Buy
9,055
+870
+11% +$60.7K 0.14% 156
2015
Q3
$633K Buy
8,185
+2,090
+34% +$185K 0.16% 152
2015
Q2
$553K Buy
6,095
+1,565
+35% +$125K 0.13% 165
2015
Q1
$341K Sell
4,530
-600
-12% -$43.1K 0.08% 256
2014
Q4
$376K Sell
5,130
-3,730
-42% -$262K 0.09% 246
2014
Q3
$625K Sell
8,860
-1,330
-13% -$87.9K 0.15% 149
2014
Q2
$575K Buy
+10,190
New +$538K 0.12% 168

Other funds holding HCA

Meiji Yasuda Asset Management's HCA Position: Q2 2026 in Review

Meiji Yasuda Asset Management reduced its HCA Healthcare (HCA) stake by 66% in Q2 2026, selling an estimated $2.14M and leaving 2,555 shares worth $996K. The position accounts for 0.04% of the portfolio, ranked #277.

Meiji Yasuda Asset Management first reported a position in HCA in Q2 2014 and has held it in 49 quarters since. The position peaked at $4.65M in Q3 2024. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Meiji Yasuda Asset Management held 2,555 shares of HCA Healthcare worth $996K as of Q2 2026.
  • Meiji Yasuda Asset Management sold 5,070 HCA Healthcare shares in Q2 2026, an estimated $2.14M.
  • HCA Healthcare made up 0.04% of Meiji Yasuda Asset Management's portfolio in Q2 2026, its #277 holding.
  • Meiji Yasuda Asset Management first reported a position in HCA Healthcare in Q2 2014 and has held it in 49 quarters since.
  • Meiji Yasuda Asset Management's HCA Healthcare position peaked at $4.65M in Q3 2024.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Meiji Yasuda Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.